Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2021	$ 293	$ 126,583,738	$ (115,899,939)	$ 211,486	$ 10,895,578
Balances (in Shares) at Dec. 31, 2021	2,926,655
Stock-based compensation		8,870,168			8,870,168
Sale of common stock for cash, net of offering costs	$ 13	3,146,927			3,146,940
Sale of common stock for cash, net of offering costs (in Shares)	132,940
Common stock issued with convertible debt		91,757			91,757
Common stock issued with convertible debt (in Shares)	3,562
Common stock issued for working capital facility	$ 1	302,999			303,000
Common stock issued for working capital facility (in Shares)	12,500
Shares issued in lieu of interest	$ 6	696,387			696,393
Shares issued in lieu of interest (in Shares)	59,980
Warrants for services with the issuance of convertible debt		449,474			449,474
Cashless stock option exercise	$ 4	(4)
Cashless stock option exercise (in Shares)	37,707				49,712
Cashless warrant exercise
Cashless warrant exercise (in Shares)	172
Warrant exercise for cash	$ 1	66,002			66,003
Warrant exercise for cash (in Shares)	4,583
Convertible note converted to common stock		50,000			50,000
Convertible note converted to common stock (in Shares)	1,690
Net loss			(24,230,220)		(24,230,220)
Foreign currency translation				(55,557)	(55,557)
Balances at Dec. 31, 2022	$ 318	140,257,448	(140,130,159)	155,929	$ 283,536
Balances (in Shares) at Dec. 31, 2022	3,179,789				3,179,789
Conversion of convertible debt into common stock	$ 235	15,331,776			$ 15,332,011
Conversion of convertible debt into common stock (in Shares)	2,348,347
Conversion of credit facility borrowings into common stock	$ 24	899,976			900,000
Conversion of credit facility borrowings into common stock (in Shares)	245,634
Warrants for services with securities purchase agreement		438,000			438,000
Stock-based compensation		487,398			487,398
Sale of common stock for cash, net of offering costs	$ 357	14,912,547			14,912,904
Sale of common stock for cash, net of offering costs (in Shares)	3,564,666
Shares issued in lieu of interest	$ 11	387,567			387,578
Shares issued in lieu of interest (in Shares)	111,516
Cashless stock option exercise
Cashless stock option exercise (in Shares)	268				938
Net loss			(19,400,376)		$ (19,400,376)
Foreign currency translation				(143,305)	(143,305)
Balances at Dec. 31, 2023	$ 945	$ 172,714,712	$ (159,530,535)	$ 12,624	$ 13,197,746
Balances (in Shares) at Dec. 31, 2023	9,450,220				9,450,220